Artios Pharma Limited

About Artios Pharma Limited

Artios Pharma is a biotechnology company focused on pioneering breakthroughs in DNA Damage Response (DDR)-based therapeutics to treat a broad spectrum of difficult-to-treat cancers. Their mission is to develop new classes of medicines exploiting DDR pathways to improve outcomes for patients with hard-to-treat solid tumors.

Products & Services

alnodesertib - ATR inhibitor:A first-in-class, selective inhibitor of ATR protein, inducing DNA damage in sensitive cancer tissue with limited effect on healthy tissue. Currently in clinical trials as an oral anti-cancer agent targeting replication stress.

ART6043 - Polθ inhibitor:The most advanced clinical Polθ program in the industry, a selective, orally bioavailable inhibitor of DNA polymerase theta. Evaluated in clinical trials in combination with olaparib for multiple tumor types.

Drug Discovery Platform (DcoDeR):A proprietary platform harnessing DDR biology to drive groundbreaking clinical development strategies through drug combinations, biomarker insights, and patient stratification.

Specialties

DNA Damage Response (DDR)-based therapeutics Cancer treatment innovations ATR inhibitors Polθ inhibitors Drug discovery platforms

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series D T: - FT: Series D	A: 115000000 MR: - FA: $115 million FAN: 115000000	D: 2025-11-17 FD: 2025-11-17	15 investors

Series D Latest

2025-11-17

$115.0M

15 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Michael T. Andriole

Chief Executive Officer and Director

C

Christine Silverstein

Chief Financial Officer

G

Graeme Smith

Chief Scientific Officer

I

Ian Smith

Chief Medical Officer

J

John Graham

VP of CMC

B

Bryony Harrop

VP of Clinical Development

View 26 more team members with Pro

Unlock Full Team Directory

Recent News